Tumor necrosis factor-α (TNF-α) inhibitors have greatly enhanced the management of inflammatory diseases such as rheumatoid arthritis (RA) and inflammatory bowel disease [1]. The gene discussed is TNF; the disease is inflammatory bowel disease.